-
Mashup Score: 0
An analysis of chronic kidney disease (CKD) trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Source: www.docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
An analysis of chronic kidney disease (CKD) trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Study findings support using the 3-year #eGFR slope as the primary slope-based outcome in randomized #CKD trials. #kidneydisease #nephtwitter #nephrology https://t.co/Q3Y4Z0yANS https://t.co/uVMTeOHmEc